Name | Number of supported studies | Average coverage | |
---|---|---|---|
type I pneumocyte | 10 studies | 24% ± 7% | |
adipocyte | 8 studies | 26% ± 7% | |
fibroblast | 7 studies | 24% ± 12% | |
epithelial cell | 5 studies | 25% ± 8% | |
smooth muscle cell | 3 studies | 25% ± 7% | |
intestinal crypt stem cell | 3 studies | 34% ± 14% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
intestine | 4 studies | 23% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 4880.20 | 966 / 966 | 91% | 48.49 | 482 / 527 |
adrenal gland | 98% | 2792.11 | 254 / 258 | 93% | 58.78 | 213 / 230 |
kidney | 93% | 2411.12 | 83 / 89 | 81% | 25.01 | 732 / 901 |
ovary | 100% | 13542.78 | 180 / 180 | 70% | 26.80 | 302 / 430 |
prostate | 91% | 3208.33 | 224 / 245 | 77% | 15.31 | 385 / 502 |
stomach | 62% | 1955.48 | 222 / 359 | 97% | 56.52 | 276 / 286 |
lung | 99% | 4244.21 | 570 / 578 | 55% | 17.51 | 638 / 1155 |
uterus | 99% | 7806.69 | 169 / 170 | 50% | 35.66 | 228 / 459 |
pancreas | 41% | 618.10 | 134 / 328 | 91% | 57.12 | 162 / 178 |
bladder | 90% | 7516.71 | 19 / 21 | 41% | 17.26 | 207 / 504 |
breast | 92% | 4112.37 | 424 / 459 | 37% | 6.65 | 413 / 1118 |
esophagus | 66% | 4131.43 | 952 / 1445 | 61% | 36.14 | 111 / 183 |
liver | 46% | 672.24 | 103 / 226 | 62% | 20.18 | 251 / 406 |
adipose | 100% | 6499.94 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 6390.42 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 9666.63 | 803 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 4953.63 | 849 / 861 | 0% | 0 | 0 / 0 |
spleen | 98% | 3029.18 | 236 / 241 | 0% | 0 | 0 / 0 |
thymus | 77% | 1412.61 | 504 / 653 | 17% | 13.67 | 104 / 605 |
brain | 24% | 483.17 | 646 / 2642 | 58% | 7.38 | 411 / 705 |
skin | 40% | 613.98 | 718 / 1809 | 34% | 11.40 | 161 / 472 |
eye | 0% | 0 | 0 / 0 | 54% | 7.73 | 43 / 80 |
tonsil | 0% | 0 | 0 / 0 | 38% | 19.32 | 17 / 45 |
lymph node | 0% | 0 | 0 / 0 | 31% | 6.48 | 9 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0048566 | Biological process | embryonic digestive tract development |
GO_0001501 | Biological process | skeletal system development |
GO_0015031 | Biological process | protein transport |
GO_0018108 | Biological process | peptidyl-tyrosine phosphorylation |
GO_0032332 | Biological process | positive regulation of chondrocyte differentiation |
GO_0035264 | Biological process | multicellular organism growth |
GO_0048286 | Biological process | lung alveolus development |
GO_0060021 | Biological process | roof of mouth development |
GO_0030154 | Biological process | cell differentiation |
GO_0030501 | Biological process | positive regulation of bone mineralization |
GO_0030282 | Biological process | bone mineralization |
GO_0042997 | Biological process | negative regulation of Golgi to plasma membrane protein transport |
GO_0035108 | Biological process | limb morphogenesis |
GO_0005576 | Cellular component | extracellular region |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0004715 | Molecular function | non-membrane spanning protein tyrosine kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0004672 | Molecular function | protein kinase activity |
Gene name | PKDCC |
Protein name | Protein kinase domain containing, cytoplasmic Extracellular tyrosine-protein kinase PKDCC (EC 2.7.10.2) (Protein kinase domain-containing protein, cytoplasmic) (Protein kinase-like protein SgK493) (Sugen kinase 493) (Vertebrate lonesome kinase) |
Synonyms | SGK493 VLK |
Description | FUNCTION: Secreted tyrosine-protein kinase that mediates phosphorylation of extracellular proteins and endogenous proteins in the secretory pathway, which is essential for patterning at organogenesis stages. Mediates phosphorylation of MMP1, MMP13, MMP14, MMP19 and ERP29 . Probably plays a role in platelets: rapidly and quantitatively secreted from platelets in response to stimulation of platelet degranulation . May also have serine/threonine protein kinase activity. Required for longitudinal bone growth through regulation of chondrocyte differentiation. May be indirectly involved in protein transport from the Golgi apparatus to the plasma membrane (By similarity). . |
Accessions | ENST00000401498.6 ENST00000294964.6 Q504Y2 F8WB71 |